Clinical Operations

Critical care trials are complex and fast-paced. Learn more about best practices for these trials from a CRO with critical care expertise.

Preparing for an upcoming ophthalmology clinical trial? Explore four critical pieces of advice from our expert team.

Looking for a CRO to support an upcoming Alzheimer’s disease clinical trial? PharPoint’s experts work as an extension of your team to strategically plan, execute, and analyze Phase 1 – Phase 4 Alzheimer’s disease clinical trials.

Should your Alzheimer’s disease clinical trial be decentralized or include virtual aspects? In this article, we discuss potential benefits.

What challenges should teams conducting blood cancer clinical trials anticipate? Learn more about common obstacles and how to overcome them.

Learn how effective site feasibility can increase your study’s speed to first patient in and maximize enrollment potential.

Neurology studies are highly complex. Explore the following 4 key considerations to successfully manage and monitor neurology trials.

RECIST criteria is not always reported accurately, and variability in tumor response assessment may be disastrous for measuring true treatment effect. Here’s how your CRO can support more consistent RECIST reads.

What do you need to consider when managing/monitoring an immuno-oncology clinical trial? Download PharPoint’s fact book to learn more.

Ms. Will joins PharPoint as the company continues to grow and engage an increasing number of biotech and pharmaceutical clients seeking personalized attention, therapeutically aligned expertise, industry-best timelines, and decentralized study options.